mk1997, I think there's room in the market for both Relenza and LANI. Relenza obviously being the cheaper, multi-dose version and LANI being the single-dose, red Ferrari version.
But I do think they need to be marketed by different companies.
- Forums
- ASX - By Stock
- BTA
- interview with peter cook
interview with peter cook, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries